Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
REPLICATION

PU.1 Binding to ets Motifs within the Equine Infectious Anemia Virus Long Terminal Repeat (LTR) Enhancer: Regulation of LTR Activity and Virus Replication in Macrophages

Robert Hines, Brenda R. Sorensen, Madeline A. Shea, Wendy Maury
Robert Hines
1Division of Basic Biomedical Science, University of South Dakota, Vermillion, South Dakota 57069
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brenda R. Sorensen
2Department of Biochemistry
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madeline A. Shea
2Department of Biochemistry
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wendy Maury
3Department of Microbiology, University of Iowa, Iowa City, Iowa 52242
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wendy-maury@uiowa.edu
DOI: 10.1128/JVI.78.7.3407-3418.2004
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
    • Open in new tab
    • Download powerpoint
    • Open in new tab
    • Download powerpoint
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    PU.1 interactions with EIAV ets motifs. (A) Model of the interaction of the PU.1 binding domain with the three EIAV binding motifs. The binding domain of PU.1, as determined by Kodandapani et al. (24), was modeled onto B-form DNA. The second helix of a helix-turn-helix motif of PU.1 binds in the major groove of the helix through interactions with the core ets motif (GGAA) that is present on the antisense strand of the EIAV enhancer. (B) Schematic of the EIAV LTR and the nucleotide sequences of the EIAV LTR enhancer ets or PU.1 sites. The Oct motif is identified below the construct because the site physically overlaps both the 5′ and middle PU.1 sites. The empty blocks within the enhancer represent 3- to 5-bp blocks of DNA that are not believed to be involved with transcription factor binding. (C) DNase I protection of the EIAV enhancer region complexed with recombinant PU.1 protein. Lanes 1 to 3, increasing concentrations of DNase I in the absence of PU.1; lane 4, probe that was not treated with DNase; lanes 5 to 7, increasing concentrations of DNase I in the presence of recombinant PU.1. The 5′ to 3′ EIAV LTR enhancer nucleotide sequence is shown in the center of the figure. Hypersensitive regions (circles) as well as PU.1-protected nucleotides (bars) at each of the three PU.1 motifs are indicated.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    PU.1 binding motifs in the EIAV enhancer differentially impact LTR activity in the canine macrophage cell line DH82. (A) Enhancer sequences tested for activity within the context of LTR/CAT constructs. (B) Basal levels of LTR activity. (C) Tat-transactivated levels of LTR activity of constructs containing the promoter-proximal (3′) PU.1 binding site (left panel) and constructs that do not contain the promoter-proximal (3′) PU.1 binding site (right panel).

    • Open in new tab
    • Download powerpoint
    • Open in new tab
    • Download powerpoint
    • Open in new tab
    • Download powerpoint
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Scatchard analysis of recombinant PU.1 binding to the three PU.1 binding motifs in the EIAV LTR. (A) Representative Scatchard plot of PU.1 binding to the 5′ PU.1 binding motif. The average disassociation constant was determined to be 4.123 nM. (B) Representative Scatchard plot of PU.1 binding to the middle PU.1 binding motif. The average disassociation constant was determined to be 3.269 nM. (C) Representative Scatchard plot of PU.1 binding to the 3′ PU.1 binding motif. The average disassociation constant was determined to be 2.609 nM. (D) Average disassociation constants of PU.1 for the three motifs within the EIAV LTR. Values represent means and standard errors of three independent experiments. The inset graphs in panels A to C demonstrate the saturation of the oligonucleotides with PU.1.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Binding curves of DH82 NE to an oligonucleotide containing the 5′ and middle PU.1 sites (5′ + mid oligonucleotide; squares) or an oligonucleotide containing the middle and 3′ PU.1 sites (mid + 3′ oligonucleotide; diamonds). All other transcription factor binding motifs that are present in that region of the EIAV LTR enhancer were altered in the oligonucleotides by the introduction of point mutations in the appropriate locations. Lines through the data were simulated by using the association constants resolved from a fit of averaged data.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Promoter-proximal location of the PU.1 site is critical for optimal Tat-transactivated expression of the LTR. (A) Constructs tested with transient transfections performed in DH82 cells. The 3′ PU.1 binding motif was substituted for both the 5′ and middle PU.1 motifs in 3′ UP. (B) Basal levels of CAT activity in DH82 cells. (C) Tat-transactivated levels of CAT activity.

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    HIV enhancer-promoter elements substitute for the EIAV elements in macrophages. (A) Constructs tested in transient transfections performed in DH82 cells. pEIA P4 (30) contains the HIV enhancer-promoter region within the context of the EIAV LTR. (B) Basal levels of expression. (C) EIAV Tat-transactivated levels of expression.

  • FIG. 7.
    • Open in new tab
    • Download powerpoint
    FIG. 7.

    Three PU.1 sites are not sufficient to support EIAV replication in equine MDMs. (A) Enhancer sequences of the molecular clones tested for infectivity. (B) RT activity of culture supernatants from EIAV-infected MDMs.

Tables

  • Figures
  • TABLE 1.

    Oligonucleotides used for PU.1 binding studiesa

    OligonucleotideSequence (5′→3′)
    5′PU.1ATA CTG TAG TTC CTC AAT ATA G
    5′PU.1 C′TTC ACT ATA TTG AGG AAC TAC A
    MidPU.1TCA ATA TAG TTC CGC ATT TGT G
    MidPU.1 C′ACG TCA CAA ATG CGG AAC TAT A
    3′PU.1CGT GTT AAG TTC CTG TTT TTA C
    3′PU.1 C′TAC TGT AAA AAC AGG AAC TTA A
    5′ + mid PU.1TCC TGT AGT TCC TCA ATA TAG TTC CGC A
    5′ + mid PU.1 C′CAA ATG CGG AAC TAT ATT GAG GAA CTA CAG G
    Mid + 3′ PU.1TCA ATA TAG TTC CGC ATT TGC TAC GCG TTA AGT TCC TG
    Mid + 3′ PU.1 C′ATA CTG TAA AAA CAG GAA CTT AAC GCG TAG CAA ATG CGG AAC
    • ↵ a Double-stranded oligonucleotides were made by annealing positive-strand oligonucleotides to their complementary (C′) partners. The core of each PU.1 binding motif is underlined. Other known transcription factor binding motifs (Oct and CRE) were eliminated from the oligonucleotides by point mutations.

PreviousNext
Back to top
Download PDF
Citation Tools
PU.1 Binding to ets Motifs within the Equine Infectious Anemia Virus Long Terminal Repeat (LTR) Enhancer: Regulation of LTR Activity and Virus Replication in Macrophages
Robert Hines, Brenda R. Sorensen, Madeline A. Shea, Wendy Maury
Journal of Virology Mar 2004, 78 (7) 3407-3418; DOI: 10.1128/JVI.78.7.3407-3418.2004

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
PU.1 Binding to ets Motifs within the Equine Infectious Anemia Virus Long Terminal Repeat (LTR) Enhancer: Regulation of LTR Activity and Virus Replication in Macrophages
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
PU.1 Binding to ets Motifs within the Equine Infectious Anemia Virus Long Terminal Repeat (LTR) Enhancer: Regulation of LTR Activity and Virus Replication in Macrophages
Robert Hines, Brenda R. Sorensen, Madeline A. Shea, Wendy Maury
Journal of Virology Mar 2004, 78 (7) 3407-3418; DOI: 10.1128/JVI.78.7.3407-3418.2004
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Infectious Anemia Virus, Equine
macrophages
Proto-Oncogene Proteins
Response Elements
Terminal Repeat Sequences
Trans-Activators
transcription factors
virus replication

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514